Petrylak

0:56

Meet Oncologist Daniel Petrylak, MD
Yale Medicine
735 views
0:57

Dr. Petrylak on Immunotherapy in Bladder Cancer
OncLive
109 views
0:38

Dr. Petrylak on FDA Approval of Pembrolizumab in Bladder Cancer
OncLive
149 views
1:47

Dr. Petrylak on Sequencing of Targeted Agents in Bladder Cancer
OncLive
29 views
0:25

Daniel P. Petrylak, MD, on the role of DNA repair gene mutations in metastatic urothelial carcinoma
OBRoncology
19 views
0:50

Dr. Petrylak on Atezolizumab in Bladder Cancer
OncLive
113 views
1:08

Dr. Petrylak on the Future Immunotherapy in Bladder Cancer
OncLive
55 views
1:01

Dr. Petrylak on Novel Immunotherapy Research in Bladder Cancer
OncLive
202 views
0:34

Dr. Petrylak Discusses Custirsen as a Potential Treatment for Prostate Cancer
OncLive
165 views
1:41

Dr. Petrylak on Immunotherapy for Second-line Treatment in Bladder Cancer
OncLive
218 views
0:37

Dr. Petrylak on FDA Approval of Nivolumab in Bladder Cancer
OncLive
229 views
1:07

Dr. Petrylak on the Results of the EV-103 Trial in Bladder Cancer
OncLive
107 views
0:41

Dr. Daniel Petrylak Discusses the Future of Abiraterone Acetate
OncLive
453 views
1:21

Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties
OncLive
233 views
45:08

Dr. Petrylak Disease Monitoring Webinar
Prostate Conditions Education Council
15 views
1:08

Dr. Daniel Petrylak Explains the Correlation Between Immune Response to Sipuleucel-T and Survival
OncLive
353 views
0:56

Dr. Petrylak on Ongoing Investigations of Checkpoint Inhibition in Bladder Cancer
OncLive
39 views
0:58

Daniel P. Petrylak, MD, on immunotherapy & chemotherapy combinations in metastatic bladder cancer
OBRoncology
19 views
1:53

Dr Daniel Petrylak Explains PD-1, PD-L1 Expression in Bladder Cancer Treatment
AJMCtv
149 views
1:05

Dr. Petrylak on PSMA ADC for Patients with mCRPC
OncLive
174 views
Today Top Searches
Categories
Recently Searched Keywords